Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-13T03:30:47.513Z Has data issue: false hasContentIssue false

The impact of vaccines and the future of genetically modified poxvirus vaccines for poultry

Published online by Cambridge University Press:  28 February 2007

Deoki N. Tripathy*
Affiliation:
Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Illinois, Urbana, Illinois 61802, USA

Abstract

The regular use of live or killed vaccines against infectious agents has remarkably improved the efficiency of poultry production. In some cases eradication of disease has been possible when the pathogen is antigenically stable and confined to a certain geographical area. In other instances monovalent or polyvalent live or killed vaccines have been effective in reducing mortality and morbidity. Many conventional vaccines are developed by trial and error and basic information about their genetic make-up is not known. While the poultry industry has benefited from the regular use of conventional vaccines, there is need for a new generation of effective vaccines that require minimal handling of birds during administration. Using molecular techniques, it is possible to identify the genes associated with virulence and protection. In genetically engineered vaccines, genes that encode protective antigens can be expressed in bacterial or viral vectors. In this regard, avianpox virus vectors appear to be promising for the generation of polyvalent vaccines expressing antigens from multiple pathogens.

Type
Research Article
Copyright
Copyright © CAB International 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Afonso, CL, Tulman, ER, Lu, Z, Zsak, L, Kutish, GF and Rock, DL (2000). The genome of fowlpox virus. Journal of Virology 7: 38153831.CrossRefGoogle Scholar
Kim, TJ, Schnitzlein, WM, McAloose, D, Pessier, AP and Tripathy, DN (2003). Characterization of an avianpox virus isolated from an Andean condor (Vultur gryphus). Veterinary Microbiology 96: 237246.CrossRefGoogle ScholarPubMed
Singh, P, Schnitzlein, WM and Tripathy, DN (2003). Reticuloendotheliosis virus sequences within the genomes of field strains of fowlpox virus display variability. Journal of Virology 77: 58555862.CrossRefGoogle ScholarPubMed
Srinivasan, V, Schnitzlein, WM and Tripathy, DN (2001). Fowlpox virus encodes a novel DNA repair enzyme, CPD-photolyase, that restores infectivity of UV light damaged virus. Journal of Virology 75: 16811688.CrossRefGoogle ScholarPubMed
Srinivasan, V, Schnitzlein, WM and Tripathy, DN (2003). A consideration of previously uncharacterized fowlpox virus unidirectional and bi-directional promoters for inclusion in homologous recombinant vaccines. Avian Disease 47: 286295.CrossRefGoogle Scholar
Tripathy, DN (1996). Fowlpox virus vectored vaccines for control of poultry diseases. In: Proceedings of the XX World's Poultry CongressNew Delhi, IndiaSeptember 2–5; Volume II pp. 497503Google Scholar
Tripathy, DN (2002). Future of the new generation of virus-vectored vaccines for efficient poultry production. In: Proceedings of the 51st Western Poultry Disease Conference(May 1–4, 2002)Puerto Vallarta, Mexico pp. 2225Google Scholar
Tripathy, DN and Hanson, LE (1986). Impact of oral immunization against duck viral hepatitis in passively immune ducklings. Preventive Veterinary Medicine 4: 355360.CrossRefGoogle Scholar
Tripathy, DN and Reed, WM (2003). Pox. In: Saif, YM, Barnes, HJ, Glisson, JR, Fadly, AM, McDougald, LR and Swayne, DE, editors. Diseases of Poultry 11th edn. Ames (IA): Iowa State University Press pp. 253269Google Scholar
Tulman, ER, Afonso, CL, Lu, Z, Zsak, L, Kutish, GF and Rock, DN (2004). The genome of canarypox virus. Journal of Virology 78: 353366.CrossRefGoogle ScholarPubMed